home / stock / stim / stim quote
Last: | $4.76 |
---|---|
Change Percent: | 0.0% |
Open: | $4.8 |
Close: | $4.76 |
High: | $4.91 |
Low: | $4.64 |
Volume: | 64,274 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.76 | $4.8 | $4.76 | $4.91 | $4.64 | 64,274 | 03-28-2024 |
$4.8 | $4.79 | $4.8 | $4.91 | $4.54 | 140,665 | 03-27-2024 |
$4.76 | $4.75 | $4.76 | $4.8 | $4.58 | 160,030 | 03-26-2024 |
$4.71 | $4.8 | $4.71 | $4.99 | $4.44 | 958,343 | 03-25-2024 |
$4.23 | $4.29 | $4.23 | $4.3658 | $3.99 | 100,125 | 03-22-2024 |
$4.29 | $4.38 | $4.29 | $4.44 | $4.19 | 158,649 | 03-21-2024 |
$4.3 | $4.26 | $4.3 | $4.44 | $4.21 | 113,606 | 03-20-2024 |
$4.27 | $3.77 | $4.27 | $4.27 | $3.69 | 114,759 | 03-19-2024 |
$3.79 | $3.94 | $3.79 | $3.99 | $3.76 | 86,216 | 03-18-2024 |
$3.9 | $3.9 | $3.9 | $4.075 | $3.8901 | 73,580 | 03-15-2024 |
$3.96 | $4.15 | $3.96 | $4.23 | $3.88 | 95,078 | 03-14-2024 |
$4.22 | $4.28 | $4.22 | $4.43 | $4.19 | 104,426 | 03-13-2024 |
$4.31 | $4.21 | $4.31 | $4.37 | $4 | 188,061 | 03-12-2024 |
$4.23 | $4.15 | $4.23 | $4.44 | $4.14 | 355,218 | 03-11-2024 |
$4.12 | $4.01 | $4.12 | $4.1783 | $3.84 | 248,391 | 03-08-2024 |
$3.97 | $4.02 | $3.97 | $4.2 | $3.8335 | 401,547 | 03-07-2024 |
$4.02 | $3.34 | $4.02 | $4.16 | $3.2743 | 560,270 | 03-06-2024 |
$3.22 | $3 | $3.22 | $3.29 | $2.9 | 343,874 | 03-05-2024 |
$2.79 | $3.01 | $2.79 | $3.1 | $2.79 | 102,199 | 03-04-2024 |
$3.01 | $3 | $3.01 | $3.1183 | $2.78 | 162,647 | 03-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
As of March 28, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in t...
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. AbbVie Inc. (NYSE: ABBV) an...
MALVERN, Pa., March 25, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced clearance from the U.S. Food and ...